Question 32599 — pharmacy and medications

Summary

Ms. Marie-Pierre Rixain draws the attention of the Minister of Solidarity and Health to the proven dangerousness of luteran and lutenyl, medications prescribed to treat the symptoms of endometriosis and menopause. The Medicines Agency (ANSM) shared, on June 17, 2020, the results of a large epidemiological investigation which confirms exposure to risks of brain tumors for women treated with luteran and lutenyl. These treatments, followed in 2019 by more than 400,000 women, would increase the risk of meningiomas by 3 to 4, or even by 12 if taken for a long time. The risks appear to be even greater depending on the age of the patient since the need to perform intracranial surgery to treat the meningioma increases sharply with age. More than two million women in France would thus be likely to be prescribed these medications and then suffer the highly undesirable and irreversible effects that they induce. Their dangerousness truly embodies a public health issue. Also, she would like to know the measures that her ministry intends to take to guarantee women's health.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.